文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

作者信息

LaBrecque Douglas R, Abbas Zaigham, Anania Frank, Ferenci Peter, Khan Aamir G, Goh Khean-Lee, Hamid Saeed S, Isakov Vasily, Lizarzabal Maribel, Peñaranda Manuel M, Ramos Juan F R, Sarin Shiv, Stimac Davor, Thomson Alan B R, Umar Muhammed, Krabshuis Justus, LeMair Anton

机构信息

Carver College of Medicine, University of Iowa, Iowa City, IA.

出版信息

J Clin Gastroenterol. 2014 Jul;48(6):467-73. doi: 10.1097/MCG.0000000000000116.

DOI:10.1097/MCG.0000000000000116
PMID:24921212
Abstract
摘要

相似文献

[1]
World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

J Clin Gastroenterol. 2014-7

[2]
[Liver diseases. Non-alcoholic fatty liver disease].

Rev Gastroenterol Mex. 2010-8

[3]
Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): prevalence, therapeutic innovations, and stumbling blocks for clinical development.

Expert Opin Investig Drugs. 2020-2

[4]
[Nonalcoholic fatty liver disease. Pathophysiologically oriented diagnosis and therapy].

Med Monatsschr Pharm. 2015-5

[5]
Foreword. Nonalcoholic Fatty Liver Disease.

Semin Liver Dis. 2015-8

[6]
Nonalcoholic fatty future disease.

Metabolism. 2016-8

[7]
How to Approach a Patient With Nonalcoholic Fatty Liver Disease.

Gastroenterology. 2017-8

[8]
Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China).

J Dig Dis. 2019-4

[9]
Nonalcoholic Fatty Liver Disease.

Can J Gastroenterol Hepatol. 2018-7-31

[10]
Nonalcoholic Fatty Liver Disease.

Clin Liver Dis. 2016-5

引用本文的文献

[1]
Myeloperoxidase, extracellular DNA and neutrophil extracellular trap formation in the animal models of metabolic dysfunction-associated steatotic liver disease.

World J Gastroenterol. 2025-7-21

[2]
Global research initiative for patient screening on MASH (GRIPonMASH) protocol: rationale and design of a prospective multicentre study.

BMJ Open. 2025-5-30

[3]
Efficacy of probiotics in patients with cognitive impairment: A systematic review and meta-analysis.

PLoS One. 2025-5-2

[4]
Gender difference in the association between serum uric acid and metabolic dysfunction-associated steatotic liver disease in patients with newly diagnosed type 2 diabetes.

BMC Gastroenterol. 2025-4-30

[5]
Trends and Disparities in Cardiovascular Disease in US Adults with Metabolic Dysfunction-Associated Steatotic Liver Disease.

Biomedicines. 2025-4-13

[6]
Efficacy of structured exercise and oat supplementation for treating non-alcoholic fatty liver disease: protocol of a randomized controlled trial.

Nutr J. 2025-4-26

[7]
The therapeutic potential of different mesenchymal stem cells and their derived exosomes in metabolic dysfunction-associated steatotic liver disease.

Front Endocrinol (Lausanne). 2025-4-3

[8]
GDF15 Circulating Levels Are Associated with Metabolic-Associated Liver Injury and Atherosclerotic Cardiovascular Disease.

Int J Mol Sci. 2025-2-26

[9]
S-Adenosylmethionine: A Multifaceted Regulator in Cancer Pathogenesis and Therapy.

Cancers (Basel). 2025-2-5

[10]
An epidemiological study on the factors including genetic polymorphism influencing ALT >30 U/L and liver fibrosis progression in metabolic dysfunction-associated steatotic liver disease among the general population.

JGH Open. 2024-12-19

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索